Award
Delivery Order #SPE2DR26FXS0X
AmerisourceBergen Awarded Delivery Order for Cisplatin Medical Supply
Buyer
Defense Logistics Agency
Award Amount
$306.00
Ceiling
$306.00
Awarded
February 12, 2026
Period of Performance
Feb 12, 2026 – Feb 13, 2026
Identifier
SPE2DR26FXS0X
NAICS
325411
This contract is a delivery order awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company. The contract involves the procurement of Cisplatin 50 MG/50 ML vials, a critical chemotherapy medication used in cancer treatment. The award is significant as it ensures the timely availability of essential cancer therapies within the specified geographic area, supporting healthcare providers and patients. The scope covers the supply and delivery of the designated pharmaceutical product within a short performance window, indicating a focused, urgent fulfillment requirement. This delivery order is associated with a larger Indefinite Delivery Vehicle (IDV) contract held by AmerisourceBergen, enhancing its role in pharmaceutical distribution. The contract was likely awarded under competitive procedures consistent with government acquisition standards. The performance period is brief, spanning two consecutive days, reflecting a targeted shipment or urgent medical supply need.
Description
4570815697!CISPLATIN 50 MG/50 ML VIAL 50ML